Omega-3 Fatty Acids and Coronary Artery Disease: More Questions Than Answers
Studies show that patients with elevated triglycerides and well-controlled LDL levels under statin therapy still have a significant residual risk of cardiovascular (CV) events. Despite many attempts to reduce triglycerides with different hypolipidemic drugs, no therapeutic option has given satisfact...
Main Authors: | Marijana Tadic, Carla Sala, Guido Grassi, Giuseppe Mancia, Stefano Taddei, Wolfgang Rottbauer, Cesare Cuspidi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/11/2495 |
Similar Items
-
The effect of Omega 3 fatty acid on the lipid profile of hemodialysis patient
by: O. Taziki, et al.
Published: (2005-01-01) -
Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial
by: Ji Eun Jun, et al.
Published: (2020-02-01) -
Treatment of Severe Hypertriglyceridemia During Pregnancy With High Doses of Omega-3 Fatty Acid and Plasmapheresis
by: Nguyen T. Nguyen, MD, et al.
Published: (2021-05-01) -
Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial
by: Omar Sheikh, et al.
Published: (2019-06-01) -
Treatment of Chinese Patients with Hypertriglyceridemia with a Pharmaceutical-Grade Preparation of Highly Purified Omega-3 Polyunsaturated Fatty Acid Ethyl Esters: Main Results of a Randomized, Double-Blind, Controlled Trial
by: Qi L, et al.
Published: (2021-09-01)